RT Journal Article
SR Electronic
T1 Stem cell transplantation in hematological disorders. A developing country experience-impact of cost considerations
JF Saudi Medical Journal
JO Saudi Med J
FD Prince Sultan Military Medical City
SP 1484
OP 1489
VO 29
IS 10
A1 El-Zimaity, Maha M.
A1 Hassan, Essam A.
A1 Abd El-Wahab, Soha E.
A1 Abd El-Ghaffar, Afaf A.
A1 Mahmoud, Nazek A.
A1 Elafifi, Amal M.
A1 Moussa, Mohamed M.
A1 El-Gohary, Ghada M.
A1 Hagras, Mona M.
A1 Mowafy, Nadia M.
YR 2008
UL http://smj.org.sa/content/29/10/1484.abstract
AB OBJECTIVE: To describe the experience in setting up a bone marrow transplant program at Ain Shams University, Cairo, Egypt.METHODS: Sixteen patients were transplanted at Ain Shams University Bone Marrow Transplantation unit from March 2005 to January 2008.RESULTS: Sixteen patients were transplanted with a median age of 25 years. Indications for transplantation were chronic myeloid leukemia, acute myeloid leukemia, aplastic anemia, acute lymphoblastic leukemia, and aggressive lymphoma. Seven donors and 6 patients were positive for cytomegalovirus immunoglobulin G (IgG) antibody (Ab) pretransplant. Only one patient was positive for toxoplasma IgG Ab and another had a high titre for toxoplasma IgM Ab pretransplant. Two donors and 2 recipients were positive for hepatitis B antibody markers; however, none were positive for hepatitis B virus DNA by polymerase chain reaction (PCR). None of the patients or donors were positive for hepatitis C virus via PCR pre-transplant. Acute graft versus host disease (GVHD) was seen in 3 patients, while chronic GVHD was seen in 5 patients. Primary cause of death was recurrence in 2 patients and graft failure in one patient. Thirteen are alive and disease free with a median follow-up of 20 months.CONCLUSION: Although our unit is a relatively new unit, these results are comparable to those achieved in the Western world and cost a mean of US$250,000.